Cristian Massacesi/LinkedIn
Nov 8, 2024, 19:17
Cristian Massacesi: How we’re building on our rich heritage in breast cancer at AstraZeneca
Cristian Massacesi, Chief Medical Officer and Oncology Chief Development Officer at AstraZeneca, shared on LinkedIn:
“Continuing this month’s ‘Let’s Talk Cancer’ series, Ingrid Mayer and I reflect on how we’re building on our rich heritage in breast cancer at AstraZeneca with our ongoing work to improve outcomes for patients.
Targeted cancer therapies and technical innovations are helping us personalize treatments in our quest to improve outcomes and redefine the standard of care.
Let us know your thoughts in the comments!
And look out for the final video in the series coming soon.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 23, 2025, 17:10
Apr 23, 2025, 16:51
Apr 23, 2025, 16:12